Condition

Rheumatoid Arthritis (RA) clinical trials and research

• 73Clinical trials
• 1New in 30 days
• 31Countries

Newest Rheumatoid Arthritis (RA) clinical trials

All recruiting trials (73)

• Heart Rate Variability and Rheumatoid Arthritis: What HRV Looks Like with RA

  This study checks whether continuous HRV data from an Oura ring can reflect RA disease activity in adults with RA.

  Recruiting University of Central Florida · Orlando, Florida · NCT07878975

• Discontinuing MTX or LEF in RA Patients on TNF Inhibitors

  This trial tests whether stopping methotrexate or leflunomide while continuing a TNF inhibitor is not worse for disease control in adults with rheumatoid arthritis.

  Recruiting Phase 4 Sint Maartenskliniek · Nijmegen, Gelderland and 3 other locations · NCT07802678

• FT839 therapy for autoimmune diseases

  This trial tests FT839, given alone or with rituximab, to see if it is safe and can help people with certain autoimmune diseases who have not responded to other treatments.

  Recruiting Phase 1/2 Fate Therapeutics · Fullerton, California · NCT07800871

• 24-Hour Movement and Atherosclerotic Risk in adults with rheumatoid arthritis

  This study tests how daily activity, sitting, and sleep relate to heart-related risk in adults with RA, using wearables and follow-up after a year.

  Recruiting São Paulo State University · Presidente Prudente, São Paulo · NCT07774507

• Integrative AI profiling of chronic RA pain

  This study tests whether an AI-driven multiomic and neurophysiological approach can help explain and predict persistent pain in adults with active rheumatoid arthritis.

  Recruiting 4th Military Clinical Hospital with Polyclinic, Poland · Wroclaw · NCT07769619

• Oxidative Stress and Heart Risk in People with Rheumatoid Arthritis

  This study tests whether certain markers of oxidative stress in people with rheumatoid arthritis are linked to subclinical atherosclerosis and arterial stiffness, which could relate to future heart disease risk.

  Recruiting University of La Laguna · Santa Cruz de Tenerife, Canary Islands · NCT07760662

• Diosmin or Rebamipide as Add‑ons to Standard RA Therapy

  This study tests whether adding diosmin or rebamipide to standard rheumatoid arthritis therapy helps patients achieve better control of their disease compared with standard therapy alone.

  Recruiting Phase 2 Tanta University · Tanta · NCT07745426

• Nicorandil for rheumatoid arthritis: a two-phase study comparing it to placebo

  This trial tests whether nicorandil twice daily for 3 months can reduce rheumatoid arthritis symptoms compared with a placebo.

  Recruiting Phase 2/3 Ain Shams University · Cairo, Abbasia · NCT07730723

• Integrated traditional and Western medicine approach for refractory rheumatoid arthritis

  This trial tests whether Kunxian Capsule, added to standard rheumatoid arthritis therapies, helps people with difficult-to-treat RA see better results.

  Recruiting Phase 4 Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine · Shanghai · NCT07721142

• JAB-8263 in active rheumatoid arthritis

  A Phase 2a open-label study tests JAB-8263 in adults with active rheumatoid arthritis to see if it is safe and can have preliminary signs of benefit.

  Recruiting Phase 2 Jacobio Pharmaceuticals Co., Ltd. · Beijing, Beijing Municipality · NCT07684157

• Predicting safe tapering of biologic therapy for rheumatoid arthritis in remission

  This study tests whether a predictive tool called OPTIBIO can help doctors decide when it’s safe to reduce biologic therapy in RA patients who are in remission.

  Recruiting at 9 sites Hospital San Carlos, Madrid · A Coruña, A Coruña and 8 other locations · NCT07678112

• Evening vs morning JAK inhibitor for rheumatoid arthritis

  This observational study tests whether taking a JAK inhibitor in the evening works better than in the morning for adults with rheumatoid arthritis.

  Recruiting Centre Hospitalier Princesse Grace · Monaco · NCT07674134

• BloodTrackR Usability and Concordance in RA

  This study tests a home blood collection device and accompanying app for people with rheumatoid arthritis to see if they can collect usable samples at home and whether the results match standard blood tests.

  Recruiting University of Ulster · Londonderry · NCT07660029

• Gluten-Free vs Mediterranean Diet in Rheumatoid Arthritis

  This study tests whether gluten-free or Mediterranean diets can affect disease activity and quality of life in people with rheumatoid arthritis over 12 weeks.

  Recruiting Hasan Kalyoncu University · Gaziantep, Şehitkamil · NCT07646262

• Desloratadine as Add-On Therapy for Rheumatoid Arthritis

  This study tests whether adding desloratadine to standard RA treatment can help reduce disease activity in adults with active rheumatoid arthritis.

  Recruiting Phase 2 Horus University · Al Mansurah · NCT07632872

• Add-on Roflumilast for active rheumatoid arthritis

  This study tests whether adding roflumilast to standard RA treatment helps reduce disease activity in adults with active rheumatoid arthritis.

  Recruiting Phase 2 Horus University · Al Mansurah · NCT07632846

• Complementary Chinese Herbal Approach to RA Management

  This trial tests a modified Si Miao Xiao Bi Tang (Chinese herbal medicine) added to methotrexate to see if it helps people with active rheumatoid arthritis.

  Recruiting Phase 2/3 Singapore General Hospital · Singapore · NCT07627893

• Effect of smartphone use on neck posture and function in RA/AS patients and healthy controls

  This study tests how smartphone use relates to neck posture, tongue pressure, balance, and neck-related disability in people with rheumatoid arthritis or ankylosing spondylitis compared with healthy individuals.

  Recruiting Necmettin Erbakan University · Konya, Meram · NCT07627542

• Carotid ultrasound to guide prevention of heart disease in inflammatory rheumatic diseases

  In people with inflammatory rheumatic diseases like RA, PsA, AxSpA, or SLE who are at modest cardiovascular risk, a carotid ultrasound test is used to see if they should start stronger lipid-lowering therapy to prevent heart problems.

  Recruiting at 7 sites Phase 4 Instituto de Investigación Marqués de Valdecilla · Alicante, Alicante and 16 other locations · NCT07611747

• KT502 first-in-human test in adults with rheumatoid arthritis

  A first-in-human, Phase 1 study will test KT502 in adults with moderately to severely active rheumatoid arthritis to see if it is safe and tolerable.

  Recruiting at 2 sites Phase 1 Kali Therapeutics, Inc. · Bayswater, Victoria and 1 other locations · NCT07564154

• Oxidative stress in autoimmune joint diseases

  Researchers will see if oxidative stress and antioxidant markers differ in adults with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.

  Recruiting University of Thessaly · Larissa, Thessaly · NCT07536529

• Ketogenic versus Carnivore (Lion) diets for inflammatory bowel disease and rheumatoid arthritis

  This trial will test whether a ketogenic diet or a carnivore (lion) diet can reduce symptoms, improve quality of life, and lower inflammation in adults with IBD or rheumatoid arthritis.

  Recruiting Fuller Research Foundation · Charlottesville, Virginia · NCT07524244

• Integrated Traditional Chinese and Western treatment for rheumatoid arthritis

  This project will try combining Traditional Chinese Medicine with Western treatments in people with rheumatoid arthritis, including those with difficult-to-treat disease and lung involvement.

  Recruiting Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine · Shanghai · NCT07484243

• Using long-lived immune cells to calm an overactive immune system

  This trial will try QEL-005, an autologous CD19-directed CAR-T regulatory cell therapy, to calm immune overactivity in adults with diffuse cutaneous systemic sclerosis or difficult-to-treat rheumatoid arthritis.

  Recruiting at 7 sites Phase 1/2 Quell Therapeutics Limited · Düsseldorf and 9 other locations · NCT07473154

• Subcutaneous methotrexate for Chinese adults with rheumatoid arthritis

  This project will test how well and how safely subcutaneous methotrexate works for Chinese adults with rheumatoid arthritis, including people with lung or coronary comorbidities.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07463937

• Lavender aromatherapy massage for wrist pain and movement in rheumatoid arthritis

  This study tests whether lavender aromatherapy massage added to usual care can reduce wrist pain and improve mobility in people with rheumatoid arthritis.

  Recruiting University of Baghdad · Hillah, Babil Governorate · NCT07456657

• S-4321 in adults with autoimmune or immune-mediated diseases

  This study tests S-4321 in adults with autoimmune conditions to see if it is safe and tolerable and to gather early data on how the drug behaves in the body and its initial effects on disease markers.

  Recruiting at 2 sites Phase 1 Seismic Therapeutic AU Pty Ltd · Charlestown, New South Wales and 1 other locations · NCT07455578

• Mediterranean versus Paleolithic diet for adults with rheumatoid arthritis

  This 12-week trial will see if following a Mediterranean or Paleolithic eating plan helps adults aged 40–60 with rheumatoid arthritis compared with continuing their usual diet.

  Recruiting Kasr El Aini Hospital · Cairo, Al-Manial · NCT07438652

• HbA1c accuracy in people with inflammatory arthritis on sulfasalazine

  This study tests whether HbA1c reliably reflects blood glucose in adults with inflammatory arthritis who are treated with sulfasalazine, by comparing it to continuous glucose monitoring.

  Recruiting Central Jutland Regional Hospital · Silkeborg, Central Jutland · NCT07416656

• TollB-001 oral tablets for moderate to severe rheumatoid arthritis

  This trial tests whether taking daily TollB-001 tablets for four weeks is safe and helps adults (18–70) with moderate to severe rheumatoid arthritis who did not respond to at least one conventional DMARD.

  Recruiting Phase 2 Toll Biotech Co. Ltd. (Beijing) · Beijing, Beijing Municipality · NCT07408024

• Long-term follow-up after KYV-101 (CAR T) treatment

  This follow-up will test how long KYV-101 CAR T cells persist and record any delayed side effects in people who previously received KYV-101 for autoimmune diseases like lupus nephritis, myasthenia gravis, stiff person syndrome, rheumatoid arthritis, or multiple sclerosis.

  Recruiting Kyverna Therapeutics · Denver, Colorado · NCT07403188

• Swallowing problems in rheumatoid arthritis

  This study will test whether a flexible fiberoptic throat exam can find joint-related swallowing problems and what predicts swallowing severity in adults with rheumatoid arthritis.

  Recruiting at 2 sites Tanta University · Tanta, Elgharbia and 1 other locations · NCT07401732

• A-319 for active rheumatoid arthritis

  This trial will test whether A-319 is safe and tolerable and may help people with active rheumatoid arthritis who have not responded to multiple prior therapies.

  Recruiting Early Phase 1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07347860

• Coronary calcium and high-sensitivity troponin testing in people with rheumatoid arthritis

  This study will test whether measuring coronary artery calcium and high-sensitivity troponin can find people with rheumatoid arthritis who should start cholesterol-lowering treatment even if general risk calculators don't recommend it.

  Recruiting at 3 sites Brigham and Women's Hospital · Boston, Massachusetts and 2 other locations · NCT07315997

• Pain neuroscience education and vagal nerve stimulation to help people with rheumatoid arthritis

  This study tests whether pain neuroscience education, vagal nerve stimulation, or a standard exercise program can improve pain, function, and quality of life for adults with rheumatoid arthritis.

  Recruiting Medipol University · Istanbul, Fatih · NCT07274124

• 100% plant-based diet for adults with rheumatoid arthritis

  This trial will test whether following a 100% plant-based diet for 16 weeks helps adults with rheumatoid arthritis lower disease activity, reduce symptoms, and improve quality of life.

  Recruiting at 2 sites Center for Clinical Research and Prevention · Frederiksberg and 1 other locations · NCT07268326

• LY4213663 in healthy people and people with rheumatoid arthritis

  This will test whether LY4213663 is safe and how the body handles it in healthy volunteers and people with rheumatoid arthritis.

  Recruiting at 9 sites Phase 1 Eli Lilly and Company · Anniston, Alabama and 9 other locations · NCT07258849

• F8IL10 injections directly into a swollen joint for rheumatoid arthritis

  This trial tests whether injecting F8IL10 into a single swollen joint is safe and what dose adults with rheumatoid arthritis can tolerate.

  Recruiting Phase 1 Philogen S.p.A. · Reggio Emilia, Reggio Emilia and 1 other locations · NCT07245992

• Comparing a one-time intramuscular steroid shot versus a short oral steroid course for RA flares

  This tests whether a single intramuscular steroid injection or a short course of oral steroid pills gives better symptom relief for people with rheumatoid arthritis who are experiencing a flare.

  Recruiting at 5 sites Phase 4 Sunnybrook Health Sciences Centre · Toronto, Ontario and 4 other locations · NCT07245732

• First-in-human KT501 for rheumatoid arthritis

  This Phase 1, open-label test will give a single under-the-skin dose of KT501 to adults with moderate to severe rheumatoid arthritis to see if it is safe and how it acts in the body.

  Recruiting Phase 1 Kali Therapeutics, Inc. · Bayswater · NCT07234773

• Peer health coaching to reduce anxiety and depression in people with rheumatoid arthritis

  This program will test whether peer health coaching helps adults with rheumatoid arthritis reduce symptoms of anxiety or depression over six months.

  Recruiting Weill Medical College of Cornell University · New York, New York · NCT07222696

• CIGB-814 safety and how the body handles it in healthy Chinese adults

  We will test whether CIGB-814 is safe, well-tolerated, and how the body processes it in healthy Chinese adults aged 18–45.

  Recruiting Phase 1 Peking University People's Hospital · Beijing, Beijing Municipality · NCT07182656

• Lowering JAK inhibitor doses in people with RA, PsA, or axSpA who are in low disease activity or remission

  This study will test whether carefully lowering the dose of Janus kinase inhibitors keeps disease control as well as staying on the same dose in people with rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis who are in remission or have low disease activity.

  Recruiting Phase 4 Sint Maartenskliniek · Nijmegen, Gelderland and 6 other locations · NCT07160231

• Personalized lab test to predict the best treatment for rheumatic diseases

  This project tests a lab-based cell assay to see if it can predict which DMARD will work best for adults with autoimmune rheumatic diseases such as RA, PsA, axSpA, and GCA.

  Recruiting University of Bonn · Bonn, North Rhine-Westphalia · NCT07150000

• 99mTc-CTR-FAPI SPECT imaging to detect inflamed joints in rheumatoid arthritis

  This trial will test whether 99mTc-CTR-FAPI SPECT scans can detect active joint inflammation as well as 68Ga-FAPI PET/CT in adults with moderate-to-high rheumatoid arthritis.

  Recruiting Peking Union Medical College Hospital · Beijing, Beijing Municipality · NCT07138729

• Long-term safety follow-up after gene-modified regulatory T cell (Treg) therapy

  This study will see if any delayed side effects occur over 15 years in people who previously got a Sonoma Biotherapeutics gene-modified Treg treatment for conditions like rheumatoid arthritis or hidradenitis suppurativa.

  Recruiting at 7 sites Sonoma Biotherapeutics, Inc. · San Francisco, California and 9 other locations · NCT07123038

• Testing ADI-001 in people with treatment-refractory rheumatoid arthritis

  This Phase 1 test will try ADI-001 with two different pre-treatment (lymphodepletion) regimens in adults whose rheumatoid arthritis has not improved with standard therapies.

  Recruiting Phase 1 Adicet Therapeutics · Shanghai, Shanghai Municipality · NCT07100873

• Butantan live tetravalent dengue vaccine for people with autoimmune rheumatic diseases

  This study will test whether a single dose of the Butantan live tetravalent dengue vaccine is safe and produces immune responses in clinically stable people aged 12–59 with autoimmune rheumatic diseases compared with matched healthy volunteers.

  Recruiting at 2 sites Phase 4 University of Sao Paulo General Hospital · São Paulo, São Paulo and 1 other locations · NCT07087912

• HBI0101 CAR-T for refractory B‑cell autoimmune rheumatic diseases

  This will test a single infusion of HBI0101 CAR‑T cells in adults with severe, treatment‑resistant B‑cell autoimmune diseases such as SLE, systemic sclerosis, idiopathic inflammatory myopathy, rheumatoid arthritis, or primary progressive MS.

  Recruiting Phase 1 Hadassah Medical Organization · Jerusalem · NCT07085676

• Training primary care providers to manage rheumatoid arthritis versus rheumatologist care

  This trial will test whether primary care doctors who completed a focused RA training program can safely manage stable adults with rheumatoid arthritis as well as their rheumatologist over one year.

  Recruiting St. Lawrence Health System · Potsdam, New York · NCT07034196

• AI-guided precision immunotherapy for rheumatoid arthritis

  This trial will see if adding the dnaJP1 peptide to hydroxychloroquine helps adults with moderately to severely active rheumatoid arthritis who have not used DMARDs or biologic treatments.

  Recruiting Phase 2 Singapore Health Services · Singapore · NCT07013110

• UTAA91 injection for refractory rheumatoid arthritis

  This trial will test whether injecting UTAA91 is safe for adults with moderate-to-severe rheumatoid arthritis that has not responded to standard treatments.

  Recruiting Early Phase 1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07001956

• Subcutaneous CLN-978 for treatment‑refractory rheumatoid arthritis

  This Phase I trial tests a subcutaneously given drug called CLN-978 that redirects T cells to CD19 to try to help people with treatment‑refractory, B‑cell–driven rheumatoid arthritis.

  Recruiting at 4 sites Phase 1 Cullinan Therapeutics Inc. · Erlangen and 3 other locations · NCT06994143

• AlloNK® therapy combined with rituximab for treating certain autoimmune diseases

  This study is testing if a new treatment called AlloNK® combined with rituximab can help people with tough-to-treat autoimmune diseases feel better.

  Recruiting at 52 sites Phase 2 Artiva Biotherapeutics, Inc. · Tuscaloosa, Alabama and 51 other locations · NCT06991114

• YTS109 cell therapy for relapsed or refractory systemic autoimmune diseases

  This trial will try a single infusion of YTS109 cells to see if it's safe and helps adults 18–65 with relapsed or refractory systemic autoimmune diseases such as SLE, systemic sclerosis, inflammatory myopathies, ANCA-associated vasculitis, or antiphospholipid syndrome.

  Recruiting Phase 1 China Immunotech (Beijing) Biotechnology Co., Ltd. · Beijing, Beijing Municipality · NCT06978647

• Single hiSC injection into the knee for rheumatoid arthritis

  This study will try a single injection of lab-made human Sertoli cells (hiSCs) into an inflamed knee to see if it helps adults with rheumatoid arthritis who still have knee swelling and pain despite standard treatment.

  Recruiting Shanghai Changzheng Hospital · Shanghai · NCT06947746

• Testing QLS12010 Capsules in Healthy Adults

  This study is testing if QLS12010 Capsules are safe and how well they are tolerated by healthy adults while also looking at how food affects the way the body absorbs the drug.

  Recruiting Phase 1 Shanghai Qilu Pharmaceutical Research and Development Center LTD · Beijing · NCT06946641

• Cizutamig for refractory seropositive rheumatoid arthritis

  This trial tests whether cizutamig, a BCMAxCD3 T‑cell engager, is safe and can help adults with seropositive rheumatoid arthritis that has not responded to other treatments.

  Recruiting Phase 1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT06946199

• Predicting response to low-dose rituximab for rheumatoid arthritis

  We will test whether a blood-based pharmacological model can predict which adults with rheumatoid arthritis will respond to a lower rituximab dose (1000 mg once per cycle).

  Recruiting University Hospital, Tours · Tours · NCT06933134

• Measuring Methotrexate Levels in Rheumatoid Arthritis Patients

  This study is testing how methotrexate levels change in people with rheumatoid arthritis when they switch from taking it by mouth to getting it as an injection, and how these levels relate to the treatment's effectiveness and safety.

  Recruiting Phase 4 Keio University · Shinjuku-ku, Tokyo · NCT06913907

• 200 mg rituximab every six months for maintenance in rheumatoid arthritis

  This will test whether giving 200 mg of rituximab every six months keeps rheumatoid arthritis under control in people already on rituximab who have low disease activity.

  Recruiting Phase 4 University Hospital, Strasbourg, France · Strasbourg · NCT06906549

• Safety evaluation of CC312 in patients with autoimmune diseases

  This study is testing a new treatment called CC312 to see if it's safe and tolerable for adults with autoimmune diseases like lupus and rheumatoid arthritis.

  Recruiting Early Phase 1 CytoCares Inc · Tianjin, China · NCT06888960

• Examining the effects of different exercise levels on arthritis symptoms

  This study tests how different amounts of exercise can help people with arthritis feel better over six months.

  Recruiting University of South Carolina · Columbia, South Carolina · NCT06880653

• At-risk rheumatoid arthritis cohort to see if exposures predict early arthritis

  This study follows people at high risk for rheumatoid arthritis to see if factors like smoking, diet, or stress can predict the development of arthritis over two years.

  Recruiting University Hospital, Montpellier · Montpellier, Hérault · NCT06876064

• Assessing exercise capacity in rheumatoid arthritis patients using a 6-minute step test

  This study is testing if a simple 6-minute step test can help people with rheumatoid arthritis measure their exercise ability better than the usual bike test.

  Recruiting Firat University · Merkez, Elâzığ · NCT06838884

• Auricular (ear) vagus nerve stimulation for rheumatoid arthritis

  This trial will test a non-invasive ear-based electrical stimulator (taVNS) to see if it lowers inflammation and improves symptoms in adults with moderate-to-severe rheumatoid arthritis who haven't responded to biologic or targeted DMARDs.

  Recruiting at 6 sites taVNS AB · Lund, Skåne County and 5 other locations · NCT06779123

• L-carnitine supplementation for rheumatoid arthritis patients

  This study is testing if adding L-carnitine to the usual treatments can help adults with rheumatoid arthritis feel better and improve their joint health.

  Recruiting Phase 2 German University in Cairo · Cairo, Demerdash · NCT06753565

• Investigating the Role of Y Chromosome Mutations in Autoimmune Diseases

  This study is trying to see how changes in the Y chromosome might affect the immune system and contribute to autoimmune diseases like Giant Cell Arteritis and Polymyalgia Rheumatica.

  Recruiting University of Bonn · Bonn, North Rhine-Westphalia · NCT06696027

• Using a wearable device to manage work-related shoulder pain

  This study is testing a wearable device that helps workers with shoulder pain by giving them feedback on their movements to see if it can make their pain and work limitations better.

  Recruiting Laval University · Québec, Quebec · NCT06693479

• JAK inhibitor tapering strategy in rheumatoid arthritis patients with low disease activity

  This study tests if lowering the dose of a JAK inhibitor is feasible for adults with rheumatoid arthritis who are in low disease activity, by comparing tapering versus staying on full-dose therapy.

  Recruiting at 24 sites Phase 4 University Hospital, Toulouse · Toulouse, Occitanie and 23 other locations · NCT06687551

• Evaluating the effects of oral AP1189 in early rheumatoid arthritis patients

  This study is testing if a new oral medication called AP1189 can help people with early rheumatoid arthritis feel better when taken with methotrexate.

  Recruiting at 11 sites Phase 2 SynAct Pharma Aps · Cutler Bay, Florida and 10 other locations · NCT06671054

• Evaluating DR-0201 for autoimmune diseases

  This study is testing a new drug called DR-0201 to see if it can help people with autoimmune diseases like lupus and Sjogren's syndrome feel better and how safe it is.

  Recruiting at 8 sites Phase 1 Sanofi · Melbourne, Victoria and 7 other locations · NCT06647069

• Evaluating COVID-19 and influenza vaccine schedules for immunocompromised individuals

  This study is testing different ways to give COVID-19 and flu vaccines to people with weakened immune systems to see which method works best for their protection.

  Recruiting at 2 sites Phase 2 McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec and 2 other locations · NCT06599658

Related topics

Quick answers

How many Rheumatoid Arthritis (RA) clinical trials are recruiting right now?

73, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 31 countries. The most sites are in China (15 trials), United States (12 trials), Egypt (7 trials), Germany (6 trials), France (5 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 13, Phase 2: 10, Phase 4: 9, Early Phase 1: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →